# COSMO Post Approval Registry: Corox OTW Steroid LV Lead Monitoring

> **NCT00396136** · PHASE4 · COMPLETED · sponsor: **Biotronik, Inc.** · enrollment: 221 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DEVICE:** Corox OTW Steroid Left Ventricular Lead

## Key facts

- **NCT ID:** NCT00396136
- **Lead sponsor:** Biotronik, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2012-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00396136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00396136, "COSMO Post Approval Registry: Corox OTW Steroid LV Lead Monitoring". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00396136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*